Atara Biotherapeutics Inc., which is developing therapies for illnesses such as kidney disease and cancer, has filed for an initial public offering (IPO), The Wall Street Journal reported on Friday. Through a family trust that owns 9.3% of Atara shares, Mexican telecom tycoon Carlos Slim Helú is one of Atara’s key investors, according to the regulatory filing.
No comments:
Post a Comment